Table 3 Patient survival or disease progression by total and stratified analyses

Total

0.47 (0.31 to 0.72)^b

<0.001

0.87 (0.51 to 1.47)^b

0.596

Subtotal by ethnicity

 White

0.67 (0.47 to 0.95)^b

0.026

1.27 (0.71 to 2.26)^b

0.420

 Asian

0.35 (0.19 to 0.64)^b

0.001

0.43 (0.21 to 0.89)^b

0.024

Subtotal by disease

 Brain glioma

0.72 (0.52 to 0.99)^b

0.045

–

–

 Prostate cancer

–

–

1.25 (0.45 to 3.48)^b

0.671

 Esophageal cancer

–

–

1.50 (0.53 to 4.22)^b

0.443

Subtotal by main pathology

 Adeno

0.47 (0.14 to 1.61)^b

0.228

1.01 (0.55 to 1.89)^b

0.965

 SCC

0.34 (0.13 to 0.93)^b

0.035

1.50 (0.53 to 4.22)^b

0.443

 Glioblastoma

0.72 (0.52 to 0.99)^b

0.045

–

–